Skip to main content

AEye Inc

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

LIDR$0.90+3.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes To Condensed Consolidated Financial Statements

AEYE,** INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data or otherwise stated)

1.ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

AEye, Inc. (the “Company” or “AEye”) is a provider of high-performance, active lidar systems for vehicle autonomy, advanced driver-assistance systems (ADAS), and smart industrial applications. AEye’s software-definable4SightTM Intelligent Sensing Platform combines solid-state active lidar and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings.

AEye, formerly known as CF Finance Acquisition Corp. III (“CF III”), was originally incorporated in Delaware on* March 15, 2016under the name CF SPAC Re Inc. On February 17, 2021,AEye Technologies, Inc., then known as AEye, Inc., entered into an Agreement and Plan of Merger with CF III. Based on CF III’s business activities, it was a “shell company” as defined under the Securities Exchange Act of1934,* as amended. On* August 16, 2021,*the business combination contemplated by the Agreement and Plan of Merger was closed and CF III changed its name to AEye, Inc.

The Company’s common stock and public warrants are listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “LIDR” and “LIDRW”, respectively. Unless otherwise specified, “we,” “us,” “our,” “AEye,” and the “Company” refers to AEye, Inc.

Unaudited Condensed Consolidated Financial Statements

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they donot include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended* December 31, 2023* included in the Company's Annual Report on Form10-K for the year ended* December 31, 2023*.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principle of Consolidation and Liquidity

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company has funded its operations primarily through the business combination and issuances of stock. As of* June 30, 2024*, the Company’s existing sources of liquidity included cash, cash equivalents, and marketable securities of $27,989.

ASC205-40, Presentation of Financial Statements - Going Concern, requires management to assess an entity’s ability to continue as a going concern withinone year of the date the financial statements are issued. In each reporting period, including interim periods, an entity is required to assess conditions known and reasonably knowable as of the financial statement issuance date to determine whether it is probable an entity willnot meet its financial obligations withinone year from the financial statement issuance date.

8

As is common in early-stage companies with limited operating histories, the Company is subject to risks and uncertainties such as its ability to develop and commercialize its products; produce and deliver lidar and software products meeting acceptable performance metrics; attract new and retain existing customers; develop, obtain, or progress strategic partnerships; secure an automotive OEM design win; secure additional capital to support the business plan; and other risks and uncertainties such as those described in Part II, Item1A of this Quarterly Report on Form10-Q.

Since its inception, the Company has incurred net losses and negative cash flows from operations. As of* June 30, 2024*, the Company had an accumulated deficit of $355,841. For thesix months ended* June 30, 2024and2023*, the Company incurred a net loss of $18,206 and $42,296, respectively, and the Company had net cash outflows from operating activities of $14,241 and $32,445, respectively. As of* June 30, 2024*, the Company had $27,989 of cash, cash equivalents, and marketable securities. As the Company is still in its early stages, it is expected to incur additional operating losses and negative cash flows as it continues to focus on achieving commercialization of its lidar solutions.

When conditions and events, in the aggregate, impact an entity’s ability to continue as a going concern, management evaluates the mitigating effect of its plans to determine if it is probable that the plans will be effectively implemented, and, when implemented, the plans will mitigate the relevant conditions or events.

The Company is dependent upon raising additional capital to provide the cash necessary to continue its ongoing operations. The Company has been able to do so; for example, during thesecond quarter of2024 it was able to raise*$5,541* in gross proceeds from financing activities. Should the Companynot be able to raise additional capital, the Company will require alternative sources of liquidity to continue its operations over the next12 months. In those circumstances, the Company would also plan to adjust spending in order to preserve and extend liquidity, and has plans to further reduce operating expenses and cash outlays should it need to. The Company believes that these plans can be successfully implemented and alleviate substantial doubt about the Company's ability to continue as a going concern, which will result in adequate cash flows to support its ongoing operations for at leastone year following the date these financial statements are issued.

Based upon the results of management’s assessment, which has been performed as of* August 7, 2024*, these condensed consolidated financial statements have been prepared on a going concern basis.

Reverse Stock Split

On* December 27, 2023*, the Company effected a1-for-30 reverse stock split of its issued and outstanding shares of common stock (the "Reverse Stock Split"). Pursuant to the Reverse Stock Split, everythirty (30) shares of issued and outstanding shares of common stock were combined intoone (1) share of common stock. The Company didnot issue fractional shares in connection with the Reverse Stock Split. Stockholders who were otherwise entitled to fractional shares of common stock were instead entitled to receive a proportional cash payment. The number of shares of common stock issuable under our equity incentive plans and exercisable under the outstanding warrants were also proportionately adjusted.

In connection with the Reverse Stock Split, there wasno change to the number of shares authorized or in the par value per share of common stock of $0.0001. Accordingly, all historical per share data, number of shares issued and outstanding, stock awards, and other common stock equivalents for the periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the Reverse Stock Split.

Concentration of Credit Risk

Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased, which mitigates risk.

The Company’s accounts receivable are derived from customers located in the U.S., Europe, and Asia-Pacific. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally doesnot require collateral.

9

Recent Accounting Pronouncements

In* December2023,* the Financial Accounting Standards Board ("FASB"), issued Accounting Standards Update ("ASU")2023-09, Income Taxes (Topic740*) - Improvements to Income Tax Disclosures*, to increase the transparency and usefulness of income tax information through improvements to the income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The guidance is effective for fiscal years beginning after* December15,* 2024. The Company is currently in the process of evaluating the effects of the new guidance.

In* November 2023,the FASB issued ASU2023*-07,* Segment Reporting (Topic280): Improvements to Reportable Segment Disclosures*. This standard requires public companies, including entities with a single reportable segment, to disclose information about their reportable segments’ significant expenses and other items on an interim and annual basis to provide more transparency about the expenses they incur from revenue generating business units. The new standard is effective for fiscal years beginning after* December 15, 2023,and interim periods within fiscal years beginning after December 15, 2024on a retrospective basis, with early adoption permitted. The Company doesnot* expect the adoption of the new standard to have a material effect on its consolidated financial statements.

2.FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities is determined in accordance with the fair value hierarchy established in FASB ASC Topic820, Fair Value Measurements and Disclosures (“ASC820”). ASC820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy of ASC820 requires an entity to maximize the use of observable inputs when measuring fair value and classifies those inputs intothree levels:

Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs, other than Level1 inputs, which are observable either directly or indirectly or can be corroborated by observable market data using quoted prices for similar assets or liabilities.

Level 3—Unobservable inputs in which there is little orno market data, which require the reporting entity to develop its own assumptions.

The Company's financial instruments that arenot remeasured at fair value include accounts receivable, prepaid and other current assets, accounts payable, accrued expenses, other current liabilities, and convertible note. The carrying values of these financial instruments approximate their fair values.

10

The Company’s financial assets and liabilities measured at fair value on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):

Fair Value Measured as of June 30, 2024 Using:
Adjusted CostUnrealized LossesFair ValueCash and Cash EquivalentMarketable Securities
Assets
Money market funds$9,464$—$9,464$9,464$—
Corporate bonds10,062(3)10,0591,2728,787
Commercial paper6,135(5)6,130—6,130
U.S. Government securities1,857—1,857—1,857
Total financial assets$27,518$(8)$27,510$10,736$16,774
Liabilities
Private placement warrant liability$—$—$—$—$—
Derivative warrant liability——39——
Total financial liabilities$—$—$39$—$—
Fair Value Measured as of December 31, 2023 Using:
Adjusted CostUnrealized GainsFair ValueCash and Cash EquivalentMarketable Securities
Assets
Money market funds$16,377$—$16,377$16,377$—
Corporate bonds2,88012,881—2,881
Commercial paper8,80958,814—8,814
U.S. Government securities7,89247,896—7,896
Total financial assets$35,958$10$35,968$16,377$19,591
Liabilities
Private placement warrant liability$—$—$—$—$—
Derivative warrant liability——26——
Total financial liabilities$—$—$26$—$—

The Company’s financial assets and liabilities subject to fair value procedures were comprised of the following:

*Money Market Funds:*The Company holds financial assets consisting of money market funds. These securities are valued using observable inputs, such as quoted prices in active markets for identical assets or liabilities.

11

Marketable Securities: The Company holds financial assets consisting of fixed-income U.S. government agency securities, corporate bonds, and commercial paper. The securities are valued using prices from independent pricing services based on quoted prices of identical instruments in less active or inactive markets. Additionally, quoted prices of similar instruments in active market or industry models using data inputs such as interest rates and prices that can be directly observed or corroborated in active markets are used to value marketable securities.

Derivative Warrant Liability: On* September 15, 2022*, the Company entered into a convertible note agreement with a face value of $10,500 (the*"2022* Note"). The Company’s derivative warrant liability includes the warrants that were issued by the Company as part of the2022 Note. The warrants are recorded on the condensed consolidated balance sheets at fair value. The fair value is based on unobservable inputs, which represent Level3 measurements within the fair value hierarchy. The fair value estimate of the warrants was based on a Monte-Carlo simulation model. Inherent in a Monte-Carlo simulation model are assumptions related to price, volatility, risk-free interest rate, term to expiration, and dividend yield. The price is based on the publicly traded price of the Company’s common stock as of the measurement date. The Company estimated the volatility for the warrants based on the historical and implied volatilities of the Company's publicly traded common stock. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the warrants. The term to expiration was calculated as the contractual term of the warrants offour years. Finally, the Company doesnot currently anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly. Changes in fair value are recognized in other income (expense) for each reporting period. Derivative Warrant Liability is included within other noncurrent liabilities on the condensed consolidated balance sheets.

Private Placement Warrant Liability: The Private Placement Warrants are recorded on the condensed consolidated balance sheets at fair value. The fair value is based on observable Level2 inputs, specifically, the observable input of the Company's public warrants, as terms of both warrants are substantially similar. Any changes in the fair value of the liability are reflected in other income (expense), net, on the condensed consolidated statements of operations and comprehensive loss. Private Placement Warrant liability is included within other noncurrent liabilities on the condensed consolidated balance sheets.

For thesix months ended* June 30, 2024*, there wereno net transfers between Level1 and Level2 inputs.

The following table presents a summary of the changes in fair value of the Company’s Level3 financial instruments for thesix months ended* June 30, 2024* (in thousands):

Derivative Warrant Liability
Balance at December 31, 2023$26
Additions—
Change in fair value included in other income (expense), net13
Balance at June 30, 2024$39

The key inputs into the Monte-Carlo simulation model for the derivative warrant liability valued at* June 30, 2024* are as follows:

Expected term (years)2.2
Expected volatility230.2%
Risk-free interest rate4.7%
Dividend yield—%
Exercise price$105.00

If factors or assumptions change, the estimated fair values could be materially different. The value of the Company’s derivative warrant liability would increase if a higher risk-free interest rate was used and would decrease if a lower risk-free interest rate was used. Similarly, a higher volatility assumption would increase the value of the liability, and a lower volatility assumption would decrease the value of the liability.

12

3.CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

Cash, cash equivalents, and restricted cash as of* June 30, 2024* and* December 31, 2023* were as follows (in thousands):

June 30, 2024December 31, 2023
(unaudited)
Cash and cash equivalents$11,215$16,932
Restricted cash2,1502,150
Total cash, cash equivalents, and restricted cash$13,365$19,082
4.INVENTORIES

Inventory, net of write-downs, as of* June 30, 2024* and* December 31, 2023* were as follows (in thousands):

June 30, 2024December 31, 2023
(unaudited)
Raw materials$246$405
Work in-process123159
Finished goods1319
Total inventory, net$382$583

The Company also had $209 and $208 of non-current inventory (raw materials), net of write-downs, classified within other noncurrent assets on the condensed consolidated balance sheet as of* June 30, 2024* and* December 31, 2023*, respectively.

The Company's current and non-current inventory as of* June 30, 2024* and* December 31, 2023* was written down by $5,097 and $5,062, respectively, in order to reduce inventory to the lower of cost or net realizable value.

5.PREPAID AND OTHER CURRENT ASSETS

Prepaid and other current assets as of* June 30, 2024* and* December 31, 2023* were as follows (in thousands):

June 30, 2024December 31, 2023
(unaudited)
Prepaid expenses$1,666$2,386
Advances to suppliers4879
Other7952
Total prepaid and other current assets$1,793$2,517

The Company's advances to suppliers as of* June 30, 2024* and* December 31, 2023* was written down by $1,385 associated with the winding down of its existing industrial product as part of its revised strategic plan. See Note13, Restructuring, for further details.

13

6.LEASES

The components of operating lease expenses for thethree andsix months ended* June 30, 2024and2023* were as follows (in thousands):

Three months ended June 30,Six months ended June 30,
2024202320242023
Operating lease cost$582$602$1,171$1,204
Variable lease cost8580169159
Total operating lease cost$667$682$1,340$1,363

Maturities of lease liabilities are as follows (in thousands):

Operating leases
Years ending - December 31:(unaudited)
2024 (remaining six months)$1,230
20252,484
20262,559
20272,636
20282,716
Thereafter8,400
Total lease payments20,025
Less amount to discount to present value(3,551)
Present value of lease liabilities$16,474
7.CONVERTIBLE NOTES

2022 Convertible Note

On* September 14, 2022*, the Company entered into a Securities Purchase Agreement with an investor allowing for the sale and issue of up totwo convertible notes, each with a principal balance of $10,500 and gross cash proceeds of $10,000, for a total of $20,000 in proceeds between thetwo issuances (each, a "Note Closing"). Thefirst Note Closing ("First Closing") occurred on* September 15, 2022*, and the Company entered into a Senior Unsecured Convertible Note with the investor pursuant to which the Company issued to the investorone convertible note ("2022 Note") with a principal balance of $10,500 for net cash proceeds of $9,850. As part of the First Closing, the Company also issued warrants to the investor. Thesecond Note Closing ("Second Closing") could have occurred up to* March 15, 2024*, upon which the Company's right to effect a Second Closing automatically terminated. As of* March 15, 2024*, the Company didnot effect a Second Closing.

The2022 Note bore interest at an annual rate of 5.0%, in addition to an original issue discount of 4.76%, and had an initial maturity date of* March 15, 2024*.

Beginning* December 14, 2022*, and thefirst trading day of each subsequent month (each a "Monthly Redemption Date" or an "Installment Date"), the Company was required to redeem the Monthly Redemption Amount until the2022 Note was fully redeemed. The Monthly Redemption Amount, in most instances, was1/15th of the original principal amount, plus any amount accelerated pursuant to the2022 Note, accrued but unpaid interest, and late fees, if any. The principal and interest could be settled in cash or, so long as certain equity conditions were met and at the option of the Company, shares of common stock, which was payable together with the Monthly Redemption Amount.

If the Company elected to settle the Monthly Redemption Amount in shares of common stock, the number of shares to be settled was based on an Installment Conversion Price equal to the lower of (i) $2.50 or (ii)95% of the lowest daily volume weighted average price of the common stock during thefive trading days immediately preceding the applicable Monthly Redemption Date. If the Company elected to settle the Monthly Redemption Amount in cash, the Monthly Redemption Amount would have included a 5% premium.

14

The investor was permitted to accelerate up tofour Monthly Redemption Amounts in any calendar month (each, an "Acceleration," and each such amount, an "Acceleration Amount", and the Conversion Date of any such Acceleration, each an "Acceleration Date") at the Acceleration Conversion Price, subject to a $2,800 limit per month. The Acceleration Conversion Price was the lower of (i) the Installment Conversion Price for such current Installment Date or (ii) the greater of $9.00 and 95% of the lowest daily volume weighted average price of the Common Stock during thefive trading days immediately preceding the Acceleration Date.

If either the relevant Installment Conversion Price or Acceleration Conversion Price, as applicable, was less than $9.00 per share, then a Conversion Floor Price Condition existed and the Company must deliver to the investor the Conversion Installment Floor Amount in cash, in addition to the required number of shares, which were valued at $9.00 regardless of the actual trading price of the Company’s shares. The Conversion Installment Floor Amount was an amount in cash equal to the product obtained by multiplying (A) the higher of (i) the highest price that the common stock traded at on the Trading Day immediately preceding the relevant Share Delivery Date and (ii) the applicable Installment Conversion Price or Acceleration Conversion Price and (B) the difference obtained by subtracting (i) the number of shares of common stock delivered to the investor on the applicable Share Delivery Date with respect to such Conversion from (ii) the quotient obtained by dividing (x) the applicable Installment or Acceleration amount subject to such Conversion, by (y) the applicable Installment Conversion Price. Interest payments were also trued-up in cash when the value of the Company’s shares was below $9.00 per share.

The Company elected to apply the fair value option to the measurement of the2022 Note. As a result of adopting the fair value option,no embedded derivatives were bifurcated from the2022 Note. The Company classified the2022 Note as a liability at fair value and remeasured the2022 Note to fair value at each reporting period. The fair value measurement included the assumption of accrued interest and expense and thus a separate amount wasnot reflected on the condensed consolidated statement of operations.

The2022 Note was fully settled through Monthly Redemptions and Accelerations in2023. As part of the debt extinguishment, the Company reclassified the accumulated change in fair value due to instrument-specific credit risk out of accumulated other comprehensive loss on the condensed consolidated balance sheet and into interest expense and other on the condensed consolidated statement of operations and comprehensive loss.

2024 Convertible Note

On* May 10, 2024*, the Company entered into a Securities Purchase Agreement with an investor for the sale and issuance of 330,823 shares of common stock and a 5-year convertible note with a principal balance of $146 ("2024 Note") for total gross cash proceeds of $1,000. The2024 Note bears interest at an annual rate equal to the Secured Overnight Financing Rate plus 1.0%, which is compounded quarterly in arrears, and has a maturity date of* June 4, 2029*. At maturity, the principal balance and accrued, unpaid and uncapitalized interest can be settled in cash, shares of common stock based on the closing price of the common stock as of the immediately preceding trading day, or any combination of the foregoing at the option of the investor. 

8.INTEREST EXPENSE AND OTHER

Interest expense and other for thethree andsix months ended* June 30, 2024and2023* consisted of the following (in thousands):

Three months ended June 30,Six months ended June 30,
2024202320242023
Amortization of premiums (accretion of discounts) on marketable securities, net$(170)$(41)$(441)$(229)
Expected credit losses20—34—
Impairment of right-of-use assets—47—47
Other9453417
Interest expense and other$(56)$11$(373)$(165)
9.ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive income (loss) by component for thesix months ended* June 30, 2024and2023* are as follows (in thousands):

Unrealized gains (losses) on available-for-sale securities
Balance at December 31, 2023$10
Other comprehensive loss, net of tax(14)
Balance at March 31, 2024$(4)
Other comprehensive loss, net of tax(4)
Balance at June 30, 2024$(8)

15

Unrealized gains (losses) on available-for-sale securitiesChange in fair value due to instrument-specific credit riskTotal
Balance at December 31, 2022$(1,254)$(25)$(1,279)
Other comprehensive income (loss), net of tax490(21)469
Balance at March 31, 2023$(764)$(46)$(810)
Other comprehensive income, net of tax420—420
Balance at June 30, 2023$(344)$(46)$(390)
10.NET LOSS PER SHARE

The following table sets forth the basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except share amounts and per share data):

Three months ended June 30,Six months ended June 30,
2024202320242023
Numerator:
Net loss attributable to common stockholders$(7,987)$(16,031)$(18,206)$(42,296)
Denominator:
Weighted average common shares outstanding - Basic6,874,4545,855,8666,499,0895,632,091
Weighted average common shares outstanding - Diluted6,874,4545,855,8666,499,0895,632,091
Net loss per share attributable to common stockholders - Basic and Diluted$(1.16)$(2.74)$(2.80)$(7.51)

Due to net losses for thesix months ended* June 30, 2024and2023*, basic and diluted net loss per share were the same, as the effect of all potentially dilutive securities would have been anti-dilutive. The following table sets forth the anti-dilutive common share equivalents for the periods listed:

Six months ended June 30,
20242023
Common stock options issued and outstanding144,287416,634
Unvested restricted stock units715,297876,578
Warrants319,443319,443
Common Stock Purchase Agreement206,780990,681
Conversion of convertible notes75,469307,841
ESPP30,679213,196
Total1,491,9553,124,373

16

11.STOCK-BASED COMPENSATION

The following table summarizes stock-based compensation expense recorded in each financial statement line item in the Company’s condensed consolidated statements of operations and comprehensive loss for thethree andsix months ended* June 30, 2024and2023* (in thousands):

Three months ended June 30,Six months ended June 30,
2024202320242023
Cost of revenue$—$34$—$95
Research and development4991,5301,7083,808
Sales and marketing36741852,042
General and administrative1,2381,8722,8614,678
Total stock-based compensation$1,740$4,110$4,754$10,623

The Company uses the Monte-Carlo simulation model to estimate the grant date fair value of awards with a market condition, which requires the input of subjective assumptions such as expected term, expected stock price volatility, risk-free interest rate and dividend yield as discussed below.

Expected Term—The expected term for awards with a market condition is the length of time from the grant date to the date the market condition expires.

Expected Volatility—Expected volatility is estimated using a combination of the average historical volatility of the Company's own stock and those of comparable companies’ stock at the time of the grant.

Risk-Free Interest Rate—The risk-free interest rates are based on US Treasury yields in effect at the grant date for notes with comparable terms as the awards.

Dividend Yield—The expected dividend-yield assumption is based on the Company’s current expectations about its anticipated dividend policy.

There wereno awards granted with a market condition during thesix months ended* June 30, 2024*.

12.REVENUE

Sale of Prototypes

The Company recorded revenue for prototype sales of $6 and $26 in thethree andsix months ended* June 30, 2024*, respectively, and $245 and $370 in thethree andsix months ended* June 30, 2023*, respectively. The Company doesnot incur significant contract costs in fulfilling or obtaining its contracts with customers.

Development Contracts

The Company has entered into research and development contracts as well as a sales, marketing and technical support services contract with companies primarily in the automotive industry. The Company assessed the number of performance obligations associated with the promises under each agreement, primarily the delivery of customized4SightTM perception-related goods and services, and recognized $26 in revenue for performance obligations satisfied during both thethree andsix months ended* June 30, 2024* and $326 and $837 during thethree andsix months ended* June 30, 2023*, respectively, in the condensed consolidated statements of operations and comprehensive loss.

17

Disaggregation of Revenue

The Company recognized the following revenues by geographic area based on the primary billing address of the customer and by the timing of the transfer of goods or services to customers (point in time or over time), as it believes such criteria best depict how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above are as follows (in thousands):

Three months ended June 30,Six months ended June 30,
2024202320242023
Revenue by primary geographical market:
United States$26$443$41$990
Europe612811160
Asia-Pacific———57
Total$32$571$52$1,207
Revenue by timing of recognition:
Recognized at a point in time$6$245$26$370
Recognized over time2632626837
Total$32$571$52$1,207

Contract Liabilities

The Company had $74 and $0 contract liabilities as of* June 30, 2024* and* December 31, 2023*, respectively.

The following table shows the significant changes in contract liabilities balance for thesix months ended* June 30, 2024and2023* (in thousands):

Six months ended June 30,
20242023
Beginning balance$—$987
Revenue recognized that was included in the contract liabilities beginning balance—(837)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period74—
Ending balance$74$150

Remaining Performance Obligations

Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and doesnot include contracts where the customer isnot committed. The customer isnot considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. Additionally, as a practical expedient, the Company hasnot disclosed the value of unsatisfied performance obligations for contracts with an original expected length ofone year or less. The contract liabilities balance represents the remaining performance obligations for contracts with an original duration of greater thanone year.

13.Restructuring

In2023, the Company implemented a revised strategic plan, which focused on key products and critical customer engagements in the Automotive market, and aligned the Company's operations with evolving business needs by focusing on a transition from research and development to the commercialization of the Company's automotive products, while winding down the existing industrial product and reducing fixed operating costs.

18

As a result of the implementation of the revised strategic plan, the Company recorded restructuring charges of $0 and $123 in thethree andsix months ended* June 30, 2024*, respectively, and $45 and $1,298 in thethree andsix months ended* June 30, 2023*, respectively, primarily relating toone-time employee termination benefits and losses on purchase commitments. Restructuring-related liabilities are included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Restructuring activity is summarized as follows as of* June 30, 2024* (in thousands):

One-time employee termination benefitsLosses on purchase commitmentsOtherTotal
Balance as of December 31, 2023$402$233$56$691
Charges18105—123
Cash payments(220)(2)(23)(245)
Balance as of March 31, 2024$200$336$33$569
Charges————
Cash payments(200)(34)—(234)
Balance as of June 30, 2024$—$302$33$335

Restructuring charges were included in the condensed consolidated statements of operations and comprehensive loss during thethree andsix months ended* June 30, 2024and2023* as follows (in thousands):

Three months ended June 30,Six months ended June 30,
2024202320242023
Cost of revenue$—$—$105$50
Research and development———503
Sales and marketing—4518558
General and administrative———187
Total restructuring charges$—$45$123$1,298
14.INCOME TAXES

For thethree andsix months ended* June 30, 2024*, the Company recognized $0 and $2 provision for income taxes, respectively. For thethree andsix months ended* June 30, 2023*, the Company recognized $19 and $38 provision for income taxes, respectively. The income tax rates vary from the federal and state statutory rates due to the valuation allowances on the Company's net operating losses and foreign tax rate differences. The Company computes its quarterly income tax provision by using a forecasted annual effective tax rate and adjusts for any discrete items arising during the quarter.

15.COMMITMENTS AND CONTINGENCIES

Legal matters

The Company* maybe subject to legal proceedings and claims that arise in the ordinary course of business. Management isnot* currently aware of any matters that will have a material effect on the financial position, results of operations, or cash flows of the Company.

16.RELATED PARTIES

From* November 2016to December 2023,the Company employed a sibling of Mr. Dussan, a director and the Company’s former Chief Technology Officer, who held the position of Director, Human Resources during2023.* For thesix months ended* June 30, 2023*, Mr. Dussan’s sibling received total cash compensation of $77 and was granted 2,000 RSUs. In addition, he participated in all other benefits that the Company generally offers to all of its employees. There wereno related party transactions for thesix months ended* June 30, 2024*.

17.SUBSEQUENT EVENTS

Management has evaluated subsequent events through* August 7, 2024* and determined that there wereno such events requiring recognition or disclosure in the condensed consolidated financial statements, other than as noted below.

On* July 25, 2024*, the Company entered into a Share Purchase Agreement ("Purchase Agreement") with an investor, in which the investor has committed to purchase, subject to certain limitations, up to $50,000 ("Total Commitment") of the Company's common stock. Under the terms and subject to the conditions of the Purchase Agreement, the Company has the right, butnot the obligation, to sell to the investor, and the investor is obligated to purchase, up to the Total Commitment. Such sales of common stock by the Company, if any, will be subject to certain limitations, and* may*occur from time-to-time in the Company’s sole discretion, commencing once certain customary conditions are satisfied, including the filing and securing effectiveness of a resale registration statement with the U.S. Securities and Exchange Commission (the “SEC”) with respect to the shares to be sold to the investor under the Purchase Agreement.

19

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.